ERIC BOERWINKLE to Receptors, Somatostatin
This is a "connection" page, showing publications ERIC BOERWINKLE has written about Receptors, Somatostatin.
Connection Strength
0.033
-
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. Sci Transl Med. 2016 06 01; 8(341):341ra76.
Score: 0.033